312 related articles for article (PubMed ID: 15861311)
1. Statins effect on smooth muscle cell proliferation.
Bellosta S; Arnaboldi L; Gerosa L; Canavesi M; Parente R; Baetta R; Paoletti R; Corsini A
Semin Vasc Med; 2004 Nov; 4(4):347-56. PubMed ID: 15861311
[TBL] [Abstract][Full Text] [Related]
2. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic effects of HMG-CoA reductase inhibitors.
Bocan TM
Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
[TBL] [Abstract][Full Text] [Related]
6. [The promise of statins].
Capurso A
Ital Heart J Suppl; 2001 Mar; 2(3):224-9. PubMed ID: 11307780
[TBL] [Abstract][Full Text] [Related]
7. [Do the pleiotropic effects of statins have a clinical significance?].
Vergès B
Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1231-5. PubMed ID: 15669365
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
10. Effect of statins on the proteasomal activity in mammalian endothelial and vascular smooth muscle cells.
Ludwig A; Friedel B; Metzkow S; Meiners S; Stangl V; Baumann G; Stangl K
Biochem Pharmacol; 2005 Aug; 70(4):520-6. PubMed ID: 15996638
[TBL] [Abstract][Full Text] [Related]
11. The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering.
Hughes AD
J Hum Hypertens; 1996 Jun; 10(6):387-90. PubMed ID: 8872802
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.
Arnaud C; Mach F
Arch Mal Coeur Vaiss; 2005 Jun; 98(6):661-6. PubMed ID: 16007821
[TBL] [Abstract][Full Text] [Related]
13. [Anti-atherosclerotic actions of HMG-CoA reductase inhibitors].
Gmiński J; Wojakowski W
Przegl Lek; 1997; 54(11):782-7. PubMed ID: 9501689
[TBL] [Abstract][Full Text] [Related]
14. Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.
Sadowitz B; Maier KG; Gahtan V
Vasc Endovascular Surg; 2010 May; 44(4):241-51. PubMed ID: 20403949
[TBL] [Abstract][Full Text] [Related]
15. Statins inhibited erythropoietin-induced proliferation of rat vascular smooth muscle cells.
Kaneda T; Tsuruoka S; Fujimura A
Eur J Pharmacol; 2010 Dec; 649(1-3):38-43. PubMed ID: 20851116
[TBL] [Abstract][Full Text] [Related]
16. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
Ito MK; Talbert RL; Tsimikas S
Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
[TBL] [Abstract][Full Text] [Related]
17. Effects of statins beyond lipid lowering: potential for clinical benefits.
Almuti K; Rimawi R; Spevack D; Ostfeld RJ
Int J Cardiol; 2006 Apr; 109(1):7-15. PubMed ID: 16054715
[TBL] [Abstract][Full Text] [Related]
18. Statins and endothelial dysfunction.
Larose E; Ganz P
Semin Vasc Med; 2004 Nov; 4(4):333-46. PubMed ID: 15861315
[TBL] [Abstract][Full Text] [Related]
19. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
Igel M; Sudhop T; von Bergmann K
Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244
[TBL] [Abstract][Full Text] [Related]
20. Statin withdrawal: clinical implications and molecular mechanisms.
Cubeddu LX; Seamon MJ
Pharmacotherapy; 2006 Sep; 26(9):1288-96. PubMed ID: 16945051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
